Yes, can't see the forest for the trees sums it up well
The point is, how much does the expertise of one of the worlds leading institutions(Cambridge)cost, and if they do find medical applications for what Phylogica can deliver them, then it's Cambridge we speak of here. Not some tin pot medical show cooking up spin for the stock market
Credentials, that's the key with this deal.
As to analogies with MicroSoft, well why not. Unlike software, medical cures have a very, very high value add component, so yes the potential with this one is mind boggling.
Let the company deal the cards, I say
Yes, can't see the forest for the trees sums it up wellThe point...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.36 |
Change
0.000(0.00%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.44 | $1.34 | $1.022M | 752.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 692 | $1.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 5666 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |